153877 Enumerating Ethnicity in the U.S. Census: It's Consequence for Hispanic/Non-Hispanic Cancer Rates

Monday, November 5, 2007: 8:35 AM

Laurie M. DeChello, MPH , Community Medicine and Health Care, University of Connecticut School of Medicine, Farmington, CT
David I. Gregorio, PhD , Community Medicine and Health Care, University of Connecticut School of Medicine, Farmington, CT
Rafael Pérez-Escamilla, PhD , Department of Nutritional Sciences and The Connecticut NIH EXPORT Center for Eliminating Health Disparities among Latinos, University of Connecticut, Storrs, CT
Changes between the 1990 and 2000 U.S. Census for enumerating ethnicity appreciably changed the numbers of Americans who identify themselves as ethnic Hispanics. The consequence of this change on estimating disparity in Hispanic/Non-hispanic (H/NH) health events is described using breast, prostate, colorectal and lung cancer incidence across Connecticut in 1994-2000, in relation to 1990 or 2000 population counts of H/NH state residents. SEER data, grouped into 3-year moving averages, were examined according to cancer site, ethnicity and gender. Risk ratios were calculated and t-tests were performed that contrasted H/NH findings. No significant differences in ratios of H/NH rates based on 1990 or 2000 census data were noted for women with breast or colorectal cancers, whereas significant differences in H/NH ratios were noted between analyses based on 1990 or 2000 census data for men with colorectal or prostate cancers. These results suggest that H/NH health disparities are intricate and that the way ethnicity is measured can affect our understanding and complicate longitudinal surveillance. In particular, attention to gender differences in ethnic identity is an important area for ongoing study.

Learning Objectives:
Describe changes in way U.S. Census enumerates hispanic ancestry. Summarize impact of change in enumeration practice on calculation of Hispanic and Non-Hispanic rates over time.

Keywords: Surveillance, Hispanic

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

See more of: Cancer Epidemiology Session 1
See more of: Epidemiology